Emulsions of perfluorocarbons
AssigneeTenax Therapeutics, Inc.
InventorsRichard Kiral, Deborah P. Thompson, Gary L. Clauson
Life of this patent
Estimating the term…
Abstract
The subject application provides for an emulsion comprising an amount of a perfluorocarbon liquid dispersed as particles within, a continuous liquid phase, wherein the dispersed particles have a monomodal particle size distribution and uses thereof. The subject application also provides for a method of nanufacturing a perfluorocarbon emulsion, a process for preparing a pharmaceutical product containing a PFC emulsion and a process for validating a batch of an emulsion for pharmaceutical use.
Claims27
An emulsion comprising an amount of a perfluoroearbon liquid dispersed as particles within a continuous liquid phase, wherein the dispersed particles have a monomodal particle size distribution.
A method of manufacturing a perfluoroearbon emulsion comprising the steps:
- a) mixing an emulsifier and aqueous medium together;
- b) adding perfluoroearbon to the mixture of step a);
- c) mixing the mixture of step b) to form a coarse emulsion;
- d) obtaining a sample of the coarse emulsion of step c) and determining particle size distribution of the sample;
- e) if the sample of step d) has a monomodal particle size distribution, then homogenizing the coarse emulsion of step c);
- and
- f) obtaining the emulsion.
A process for preparing a pharmaceutical product containing a PFC emulsion, the process comprising:
- a) obtaining a batch of perfluoroearbon emulsion or coarse emulsion;
- b)1) determining the particle size distribution of the batch;
- 2) determining the total amount of residual fluoride present in the batch;
- or
- 3) determining the total amount of lysophosphatidylcholine (LPTC) present in the batch;
- and
- c) preparing the pharmaceutical product from the batch only if 1) the batch is determined to have a monomodal particle size distribution;
- 2) the batch is determined to have less than 40 ppm residual fluoride by weight of the emulsion;
- or 3) the batch is determined to have less than 7 g/L lysophosphatidylcholine (LPTC) by weight of the emulsion.
A process for validating a batch of an emulsion for pharmaceutical use, the process comprising:
- a)1) determining the particle size distribution of a sample of the batch;
- 2) determining the total amount of residual fluoride in a sample of the batch;
- or
- 3) determining i the total amount of lysophosphatidylcholine (LPTC) in a sample of the batch;
- and
- b) validating the batch for pharmaceutical use only if 1) the sample of the batch has a monomodal particle size distribution;
- 2) the batch contains less than 40 ppm residual fluoride by weight of the emulsion;
- or 3) the batch contains less than 7 g/L lysophosphatidylcholine (LPTC) by weight of the emulsion.
Dependencies are inferred from the claim text.